GLOBUS MEDICAL, INC. (GMED)

82.97 +0.52% (+0.43)

Over 1M: +5.3%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

80 85
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 769M Q3 '25 — Operating Cash Flow: 249.7M Q3 '25 — Free Cash Flow: 213.9M Q3 '25 — Net Income: 119M Q4 '25 — Revenue: 826.4M Q4 '25 — Operating Cash Flow: 248.6M Q4 '25 — Free Cash Flow: 202.4M Q4 '25 — Net Income: 140.6M Q1 '26 — Revenue: 759.9M Q1 '26 — Operating Cash Flow: 202.4M Q1 '26 — Free Cash Flow: 162.7M Q1 '26 — Net Income: 124.3M Q2 '26 — Revenue: 789.6M Q2 '26 — Operating Cash Flow: 209.7M Q2 '26 — Free Cash Flow: 176.6M Q2 '26 — Net Income: 151.6M 0 200M 400M 600M 800M 1B
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.6
OE margin 22.5%
Oper. margin 20.3%
ROIC 12.1%
Accruals -6.8%
FCF margin 24.0%
Gross margin 68.5%
ROA 9.8%
OCF / EBIT 1.4×
OCF margin 28.9%
ROCE 12.8%
ROE 11.2%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.1
RPO / sales 0.0089×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.5
ND/EBITDA —
Cash / Debt 826.6×
Debt / Eq 0.00015×
Debt payback 0.0 yr
F-score 9.0 pts
Payout 0.0%
Quick ratio 2.9×
Cash runway —
Interest cover —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.1
Sales CAGR 4Y +32.3%
Sales/sh Y/Y +20.4%
EBIT CAGR +34.3%
EBIT Y/Y +127.2%
EPS CAGR 4Y +28.4%
Shares change -0.59%
EPS Y/Y +51.0%
Sales Q/Q +5.9%
Div. growth —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.